Sign up for the QMED & MD+DI Daily newsletter.
Biocompatibility as a Critical Design InputBiocompatibility as a Critical Design Input
July 23, 2024
48 Min View
Date: Jul 23, 2024
Duration: 48 Min
Already have an account?
Sponsored by Nelson Laboratories
Biocompatibility evaluation must accompany any medical device that has contact with a patient during use and is a requirement before a device can be cleared for market. This is usually the last step in device development and should be performed per ISO 10993-1. While biocompatibility should be assessed using the final finished device, it should not be considered as an afterthought, but instead be an active component of the design process.
Attend this webinar and learn:
What biocompatibility is, and what should be considered when performing a biological evaluation
The importance of choosing the appropriate materials from the beginning of the design phase to address potential changes caused by supply chain issues
Practical guidance for conducting biological evaluations in compliance with ISO 10993-1 with awareness of US FDA’s harmonization efforts.
You May Also Like
.png?width=300&auto=webp&quality=80&disable=upscale)
_(2).png?width=300&auto=webp&quality=80&disable=upscale)